- Open Access
International veterinary epilepsy task force consensus report on epilepsy definition, classification and terminology in companion animals
BMC Veterinary Researchvolume 11, Article number: 182 (2015)
Dogs with epilepsy are among the commonest neurological patients in veterinary practice and therefore have historically attracted much attention with regard to definitions, clinical approach and management. A number of classification proposals for canine epilepsy have been published during the years reflecting always in parts the current proposals coming from the human epilepsy organisation the International League Against Epilepsy (ILAE). It has however not been possible to gain agreed consensus, “a common language”, for the classification and terminology used between veterinary and human neurologists and neuroscientists, practitioners, neuropharmacologists and neuropathologists. This has led to an unfortunate situation where different veterinary publications and textbook chapters on epilepsy merely reflect individual author preferences with respect to terminology, which can be confusing to the readers and influence the definition and diagnosis of epilepsy in first line practice and research studies.
In this document the International Veterinary Epilepsy Task Force (IVETF) discusses current understanding of canine epilepsy and presents our 2015 proposal for terminology and classification of epilepsy and epileptic seizures. We propose a classification system which reflects new thoughts from the human ILAE but also roots in former well accepted terminology. We think that this classification system can be used by all stakeholders.
Epilepsy is a complex brain disease where sudden and abnormal activity in neuronal networks causes the prominent clinical sign of seizures characterised by motor, autonomic and/or behavioural features. Epileptic seizures are episodic and brief (in most cases less than 2–3 min). Epilepsy can rise from a plethora of causes. A few rare cases are purely genetic (e.g. channelopathies), some are developmental and have complex genetic and epigenetic influences (e.g. neuronal migration disorders) and some are caused by injury to the brain (e.g. trauma, infectious, inflammatory, vascular or neoplastic disease). In a significant number of cases, the cause is not clear. Although the mechanisms behind companion animal epilepsy are largely uncovered, it is clear that epilepsy in some purebred dogs is a direct result of a genetic defect, where seizures are the core clinical sign of disease. This has been described for the Lagotto Romagnolo, Belgian shepherd and Boerboels [1–4]. A high epilepsy prevalence in a specific breed or the accumulation of epileptic individuals within specific dog families are strong indicators of inherited epilepsy, but often it is unknown if genetic defects are the sole cause of the epilepsy or if the epilepsy might arise from multifactorial causal influences including environmental, developmental, provoking and genetic factors, and similar issues apply to human cases .
The true prevalence of epilepsy in dogs is unknown and has been estimated to be 0.6–0.75 % in the general dog population [6, 7]. Epidemiological population prevalence studies in specific breeds with idiopathic epilepsy has been conducted in the Labrador retriever (3.1 %), Belgian shepherd (9.4 %) and petit Basset Griffon vendeen (8.9 %), and pedigree studies in the Boxer, Irish wolfhound, English Springer spaniel, Vizsla, Bernese mountain dog, Standard poodle, Belgian shepherd, Border collie, Australian shepherd and Border terrier among others, and these have provided evidence for inherited epilepsy [8–25] (for further information on epilepsy related to specific breeds see Hülsmeyer et al. ). Given the heterogeneity of epilepsy where causes and signs of disease are greatly variable, a standardised terminology and classification system for epilepsy is crucial in order to provide accurate descriptive information for diagnostic and communicative processes.
Since 1964 epilepsy and epileptic seizures have in human medicine been organized and categorized in a classification and terminology system, published by the International League Against Epilepsy—ILAE [27–33]. The ILAE sees itself as “the world's preeminent association of physicians and other health professionals working towards a world where no persons’ life is limited by epilepsy” and the noble mission of this organization is “to ensure that health professionals, patients and their care providers, governments, and the public world-wide have the educational and research resources that are essential in understanding, diagnosing and treating persons with epilepsy” (ILAE homepage www.ilae.org).
The 1985 classification of seizure types and the 1989 classification of the epilepsies continues to be used worldwide in human epilepsy [32, 34]. However, in recent years, the ILAE classification task force has taken to continually updating and revising on the subject of epilepsy producing new consensus documents approximately every 5 years with the most recent being published in 2010 and a further version is currently under much debate . The terminology and classification framework they provide is seen as an ever evolving process, reflecting the constant gain in our understanding of the disease and the complications inherent in ambiguous, misinterpreted and potentially stigmatising vocabulary. This has generated considerable discussion amongst their members reflecting the complexity of the task.
In veterinary medicine, a number of classification proposals for canine epilepsy have been published over the years always reflecting in part the current ILAE proposals (e.g. [35–38]). There remains, however, a lack of a consensus, a common ‘language’, for the classification and terminology used between veterinary and human neurologists and neuroscientists, practitioners, neuropharmacologists and neuropathologists. Companion animal epilepsy papers reflect a variety of modifications of the definitions of epilepsy and epileptic seizures derived from the core classification documents of the ILAE (e.g. [1, 7, 9–15, 17, 23–25, 27, 28, 30–36, 38–46]. This has led to an unfortunate situation where different veterinary publications and textbook chapters on epilepsy merely reflect individual author preferences with respect to terminology, which can be confusing for the reader. Put in a scientific and educational perspective, the existing lack of uniformity with respect to definitions and terminology furthermore represents a major problem, as comparisons between research studies are compromised. Even more important, it prevents the implementation of a common understanding of epilepsy and standardized professional guidelines which can help clinicians when diagnosing animals with epilepsy and advising the owners.
Terminology and classification of epilepsy should be a ‘user friendly’, reliable and valid tool for the benefit of different users and the patient . There is a ‘chain of care’ from the pet’s owner through the primary clinician to neurology specialists and researchers. The language should be concise to reduce errors and to simplify conversation. The first opinion veterinarian and specialists alike should be able to use the classification framework to manage the disease appropriately and to communicate with others using the same language. In the age of the internet, the pet owner also needs to be able to, at least in part, comprehend the terminology used. The scientist should find in the classification a pragmatic and reliable instrument to investigate the disease’s aetiology, pathophysiology, treatment, and outcome. Finally terminology should reflect current knowledge and not be changed for the sake of change, which has recently also been emphasized by Shorvon (2014)  and others with respect to the ILAE discussions on classification. Otherwise important historical data might be lost and in some cases it might be wise to stay with terms which are in widespread use and have stood a test of time instead of a rapid change of terminology emanating from academic discussions . Considering these issues, terminology and classification needs to fulfil dissimilar and sometimes antagonistic needs and at the same time be adaptable to change.
In adopting the terms associated with human epilepsy we should acknowledge some of the very significant differences when applying it to small animal patients. We cannot interview our patients as in human medicine and the clinician’s interpretation of the patient’s seizure signs are invariably restricted to the owner's description and often a poor quality video(s). Typically electroencephalography (EEG) is an impractical tool in animals and so cannot contribute to a general classification scheme—in contrast to the situation in human medicine. Furthermore some owners will decline diagnostic investigation due to financial concerns or because some procedures require general anaesthesia, and therefore the owners’ report of seizure history and phenomenology, supported by digital (video) recordings, remain the most central diagnostic epilepsy marker in companion animals (in fact as it does in humans).
Another discrepancy between people and animals which must be addressed is the assessment of possible impairment of consciousness during seizures. The determination of consciousness impairment is challenging and often very important to people because of personal and public safety. The ILAE classification cites consciousness as an important factor for diagnosis. Veterinary medicine is better aligned with the challenges facing paediatric medicine in this regard.
This consensus statement group aims to provide the veterinary community with a proposal focused on the classification of epilepsy and epileptic seizures. To ensure we have all stakeholders involved, the consensus-working group is composed of veterinary and human neurologists and neuroscientists, practitioners, neuropharmacologists and neuropathologists.
In recent years the ILAE has been able to advance human epilepsy classification to a sophisticated level as a consequence of advanced diagnostics and the uncovering of an increasing number of mechanisms (including genetic) that lead to epilepsy. The definition of epilepsy accepted by the ILAE in 2005 reflected the immense progress with respect to the identification of aetiologies and the understanding of seizure generation. Here an epileptic seizure was defined as: “A transient occurrence of signs and/or symptoms due to abnormal excessive or synchronous neuronal activity in the brain”, and epilepsy was defined as: “A disorder of the brain characterized by an enduring predisposition to generate epileptic seizures and by the neurobiologic, cognitive, psychological, and social consequences of this condition. The definition of epilepsy requires the occurrence of at least one epileptic seizure” . In 2010 the ILAE refined the definitions even further ; to demonstrate the on-going discussions in the ILAE, it has recently been proposed that epilepsy should be considered a true disease of the brain . This contradicts the previous understanding of epilepsy as a condition of the brain—or a collection of signs from the brain. Berg and Scheffer stated back in 2011 : “These proposals are not meant to be permanent, but form part of a transition to a system that will ultimately allow for meaningful translation of scientific understanding to the classification of the epilepsies for clinical and other purposes”. Although we need to move veterinary epilepsy classification forward we also must, as in human medicine, consider carefully whether any change of terminology is meaningful ; we must accept that currently we have not advanced the scientific understanding of the mechanisms leading to epilepsy in companion animals to the level applicable to the ILAE.
In the following sections the IVETF discusses the current understanding of companion animal epilepsy and presents our 2015 proposal for terminology and classification of epilepsy and epileptic seizures. We propose a classification system which reflects new thoughts from the human ILAE but also has its roots in former well accepted terminology. We think that this classification system can be used by all stakeholders. The classification has two elements: (a) an aetiological element and (b) a seizure type classification.
In human medicine, epilepsy can often be confirmed by electroencephalography (EEG) although epileptic people may have a normal EEG and an abnormal EEG can also exist in people without epilepsy. The use of EEG in veterinary medicine is currently of questionable routine clinical value and therefore our definitions should be seen as clinically operational and reflecting expert knowledge in the field with respect to the typical appearance of epileptic seizures and their symptomatology. This is not a major drawback, and for definition purposes, it is reasonable (in human and animal epilepsy) to define seizures and epilepsy by the clinical appearance of seizures. Please also refer to the glossary for further definitions not listed in the main text.
The term can be used for any sudden, short lasting and transient event. It does not imply that the event is epileptic.
Manifestation(s) of excessive synchronous, usually self-limiting epileptic activity of neurons in the brain. This results in a transient occurrence of signs which may be characterized by short episodes with convulsions or focal motor, autonomic or behavioural features and due to abnormal excessive and/or synchronous epileptic neuronal activity in the brain.
A reactive seizure is a seizure occurring as a natural response from the normal brain to a transient disturbance in function (metabolic or toxic in nature)—which is reversible when the cause or disturbance is rectified. A provoked seizure can be considered as being synonymous with a reactive seizure.
Epilepsy is defined as a disease of the brain characterized by an enduring predisposition to generate epileptic seizures. This definition is usually practically applied as having at least two unprovoked epileptic seizures >24 h apart .
Historically veterinary medicine has operated with various terminology/synonyms for epilepsy types defined by aetiology and phenotypic manifestations which are themselves defined by the distribution of abnormal electrical activity in the brain. The development of ILAE classifications and changes in veterinary epilepsy terminology throughout time are detailed in Table 1 and 2.
Epilepsy types defined by aetiology
(idiopathic defined as a disease in its own right, per se) should be seen as the overarching and bridging term, which can be sub-classified into three sub-groups reflecting the advancements in the field:
Idiopathic epilepsy (genetic epilepsy)—a causative gene for epilepsy has been identified/confirmed genetic background
Idiopathic epilepsy (suspected genetic epilepsy)—a genetic influence supported by a high breed prevalence (>2 %), genealogical analysis and/or familial accumulation of epileptic individuals*,**.
* Shorvon stated in 2014 : “It seems very likely that the genetic influences in idiopathic epilepsies probably are complex involving multiple genes and interactions between genes (epistatic) and between genes and the environment (epigenetic)”.
** A list of breeds with a high epilepsy incidence or prevalence compared to the general background population can be found in Hülsmeyer et al. . Please note that the epilepsy status within breeds may fluctuate over time and furthermore be influenced by differences between countries (e.g. due to preferences with respect to currently popular breeding lines).
Idiopathic epilepsy (epilepsy of unknown cause)—epilepsy in which the nature of the underlying cause is as yet unknown and with no indication of structural epilepsy.
Please see consensus on Diagnostic approach to epilepsy in dogs  for further information on diagnostic work-up.
is characterized by epileptic seizures which are provoked by intracranial/cerebral pathology including vascular, inflammatory/infectious, traumatic, anomalous/developmental, neoplastic and degenerative diseases confirmed by diagnostic imaging, cerebrospinal fluid examination, DNA testing or post mortem findings (see consensus on Diagnostic approach to epilepsy in dogs ). Lafora disease progressive myoclonic epilepsy would be classified under structural epilepsy as the gene defect results in a storage disease which alters the brain structurally and where the epileptic seizures associated with the structural changes in the brain are one of the multiple clinical and neurological signs associated with the primary storage disease .
Classification by seizure semiology (seizure type classification)
Focal epileptic seizures
Focal epileptic seizures are characterized by lateralized and/or regional signs (motor, autonomic or behavioural signs, alone or in combination). The ictal onset is consistent from one epileptic seizure to another. They may be discretely localised or more widely distributed. Focal epileptic seizures may originate in subcortical structures, with preferential propagation patterns that can involve the contralateral hemisphere. With focal epileptic seizures, the abnormal electrical activity arises in a localized group of neurons or network within one hemisphere. The clinical signs reflect the functions of the area or areas involved.
Focal epileptic seizures can present as:
Motor (episodic focal motor phenomena e.g. facial twitches, repeated jerking head movements, rhythmic blinking, twitching of facial musculature or repeated rhythmic jerks of one extremity)
Autonomic (with parasympathetic and epigastric components e.g. dilated pupils, hypersalivation or vomiting)
Behavioural (focal epileptic seizure activity which in humans can represent psychic and/or sensory seizure phenomena may in animals result in a short lasting episodic change in behaviour such as e.g. anxiousness, restlessnesss, unexplainable fear reactions or abnormal attention seeking/‘clinging’ to the owner.
Generalized epileptic seizures
Generalized epileptic seizures are characteried by bilateral involvement (both sides of body and therefore both cerebral hemispheres involved). Generalized epileptic seizures may occur alone or evolve from a focal epileptic seizure start. In dogs and cats generalized epileptic seizures predominantly present as tonic, clonic or tonic-clonic epileptic seizures. As a rule the animal will lose consciousness during convulsive epileptic seizures (myoclonic seizures excluded). Salivation, urination and/or defecation furthermore often also occur (myoclonic seizures excluded).
Generalized convulsive epileptic seizures involving bilateral motor activity
Myoclonic (Jerking movements usually affecting both sides of the body)
Non-convulsive generalized epileptic seizures
Atonic (also called ‘drop attacks’—sudden and general loss of muscle tone which usually cause the animal to collapse)
Focal epileptic seizures evolving into generalized epileptic seizures
Focal epileptic seizures can spread from initial regional cerebral involvement to bilateral cerebral involvement. The seizure will start with regional motor, autonomic and/or behavioural signs and then rapidly be followed by a convulsive stage with bilateral tonic, clonic or tonic-clonic activity and loss of consciousness. This is the most common seizure type observed in the dog. The onset of the focal epileptic seizure is often very short (seconds to minutes) after which follows the secondary generalisation with convulsions. The focal epileptic seizure onset may be difficult to detect due to its brief nature. When taking the seizure history, clients should be interviewed thoroughly about what (or if something) happens before convulsions (please see De Risio et al.  for further information on diagnostic work-up).
The semiological description of an epileptic seizure
If classification is to be carried out according to seizure type, it makes sense to have a systematic way of describing seizures. The evolution of the seizure over time is what is important.
Phases associated with epileptic seizures
The epileptic seizure is classified as the ictus (seizure activity)—followed by a postictal phase (where the normal brain function is restored). The ictus may consist of a generalized epileptic seizure alone, a focal epileptic seizure alone, or a focal epileptic seizure which evolves into a generalized seizure. In the postictal phase, the brain restores its normal function. The postictal phase may be very short or last for several hours to days. Typically, the animal is disoriented, may have behavioural abnormalities such as repetitive vocalisation, compulsive locomotion failing to avoid obstacles, be tired, ataxic, hungry or thirsty, express a need to urinate, defecate or appear exhausted and sleep for a longer period of time. Postictal blindness or aggression may also be present.
In some animals (but not so common), ictus may be preceded by a so-called prodrome, a long-term (hours to days) change in disposition and indicator of forthcoming seizures. Humans may experience days of, for example, irritability, withdrawal or other emotional aberrations. In dogs the most common prodromal signs described are hours or days of restlessness, anxiousness, appear as being irritated (e.g. with uncharacteristic aggression towards other pets), or attention-seeking behaviour which is known to the owner as a long-term marker of a forthcoming seizure episode. Prodromes (if present) can represent a potential important therapeutic window for pulse therapy. Prodromal signs must be discriminated from focal seizure signs. Prodromal signs are defined by their long lasting nature whereas focal seizures which may display similar signs when they occur alone or before generalized convulsive seizures are very short (seconds to minutes).
Consciousness in focal epileptic seizures
Variable to no impairment of consciousness may appear during focal seizures. However, we propose that no attempt should be made to evaluate if consciousness is unimpaired or impaired (previously described as simple or complex focal (or partial) seizures respectively). Although animals may appear as if consciousness is impaired during focal epileptic seizures (awake but being confused, not recognizing the owner, not responding to commands) we cannot assess this objectively. It will always be a subjective interpretation in animals that cannot report what they are experiencing. Therefore it is not meaningful to subclassify focal epileptic seizures using consciousness.
Agreed modified glossary of descriptive terminology for ictal semiology in accordance with the ILAE guidelines (based on Blume et al. )
The glossary of descriptive terminology was discussed within the IVETF in 2014. The terms that the majority of the group (>50 % of 95%CI from 14 raters) felt could be also used to describe ictal semiology are listed below:
I. General terms
Semiology That branch of linguistics concerned with clinical signs.
Epileptic seizure Manifestation(s) of excessive synchronous, usually self-limiting epileptic activity of neurons in the brain. This results in a transient occurrence of signs which may be characterized by short episodes with convulsions or focal motor, autonomic or behavioural features and due to abnormal excessive or synchronous epileptic neuronal activity in the brain.
ICTUS A sudden neurological occurrence such as a stroke or an epileptic seizure.
Epilepsy Epilepsy is defined as a disease of the brain characterized by an enduring predisposition to generate epileptic seizures. This definition is usually practically applied as having at least two unprovoked epileptic seizures >24 h apart .
Focal epileptic seizures are conceptualized as originating within networks limited to one hemisphere. They may be discretely localized or more widely distributed. Focal epileptic seizures may originate in subcortical structures. For each epileptic seizure type, ictal onset is consistent from one seizure to another, with preferential propagation patterns that can involve the contralateral hemisphere .
Generalised epileptic seizure An epileptic seizure whose initial semiology indicates, or is consistent with, more than minimal involvement of both cerebral hemispheres. Generalized epileptic seizures are conceptualized as originating at some point within, and rapidly engaging, bilaterally distributed networks .
Convulsion Primarily a lay term. Episodes of excessive, abnormal muscle contractions, usually bilateral, which may be sustained or interrupted.
II. Terms describing epileptic seizure semiology
These are descriptors of seizures unless specified otherwise.
Motor Involves skeletal musculature resulting in any phenotypic manifestation. The motor event could consist of an increase (positive) or decrease (negative) in muscle contraction to produce a movement. Unless noted, the following terms are adjectives modifying “motor seizure” or “seizure” e.g. “tonic motor seizure or dystonic seizure”, and whose definitions can usually be understood as prefaced by: “refers to …”.
Tonic A sustained increase in muscle contraction lasting a few seconds to minutes.
Versive A sustained, forced conjugate ocular, cephalic and/or truncal rotation or lateral deviation from the midline.
Dystonic Sustained contractions of both agonist and antagonist muscles producing athetoid or twisting movements which when prolonged may produce abnormal postures.
Myoclonic (adjective); Myoclonus (noun) Sudden, brief (<100 msec) involuntary single or multiple contraction(s) of muscles(s) or muscle groups of variable topography (axial, proximal limb, distal).
Clonic Myoclonus which is regularly repetitive, involves the same muscle groups, at a frequency of about 2–3 seconds, and is prolonged. Synonym: rhythmic myoclonus.
Tonic-clonic A sequence consisting of a tonic followed by a clonic phase. Variants such as clonic-tonic-clonic may be seen.
Generalised tonic-clonic epileptic seizure (Formerly "Grand Mal" Seizure) Noun: Bilateral symmetrical tonic contraction then bilateral clonic contractions of somatic muscles usually associated with autonomic phenomena.
Atonic Sudden loss or diminution of muscle tone without an apparent preceding myoclonic or tonic event lasting one to two seconds or more, involving head, trunk, jaw or limb musculature.
Synchronous (Asynchronous) Motor events occurring (not) at the same time or at the same rate in sets of body parts.
Automatism Noun: A more or less coordinated, repetitive, motor activity usually occurring when cognition is impaired and for which the subject is usually amnesic afterwards. This often resembles a voluntary movement, and may consist of inappropriate continuation of ongoing preictal motor activity.
The following adjectives are usually employed to modify “automatism”.
Oroalimentary Lip smacking, lip pursing, chewing, licking, teeth grinding or swallowing.
Pedal Indicates principally distal component involvement, bilateral or unilateral. Usually running movement.
Aura* Noun: A ‘subjective’ ictal phenomenon that, in a given patient, may precede an observable seizure; if alone, constitutes a sensory seizure. This can result in behavioral changes such as fear, aggression, searching behaviour, attention, body sensation.
*What is an aura? Commonly owners report that they can foresee a motor seizure when specific, and to the owner, well known signs repeatedly appear within seconds or minutes prior to convulsions. The term aura has in the past been used to describe such a forewarning of convulsions. This term originated from human epileptology where aura in early ILAE classifications was used “to denote symptomatology that encompasses subjective sensory phenomena as well as vegetative signs (for example, the epigastric sensations accompanying mesial temporal epilepsy)” and thus did not include motor phenomena. The group recommends that the term aura is not used in veterinary medicine. The signs occurring as the first indication of seizure activity (marking the beginning of ictus) and interpreted by the dog owner as a warning sign is indeed a focal seizure onset and should be referred to as such.
Autonomic A sensation consistent with involvement of the autonomic nervous system, including cardiovascular, gastrointestinal, sudomotor, vasomotor and thermoregulatory functions. In companion animals, salivation, mydriasis, urination and/or defecation may commonly be observed.
Unilateral Exclusive or virtually exclusive involvement of one side as a motor, sensory or autonomic phenomenon.
HEMI- A prefix to other descriptors e.g. hemiclonic.
Generalised (syn. “bilateral”) More than minimal involvement of each side as a motor or autonomic phenomenon.
Motor component: further modified as:
Asymmetrical Clear distinction in quantity and/or distribution of activity on the two sides.
Symmetrical Virtual bilateral equality in these respects.
Body part Refers to area involved i.e. limb, face, trunk and other.
Axial Involves trunk, including neck.
Proximal limb Signifies involvement from shoulders to metacarpus, hip to metatarsus.
Distal limb Indicates involvement of paws.
Modifiers and descriptors of epileptic seizure timing The following terms are listed in the form (adjective, noun, verb) according to principal usage; as adjective unless specified.
Incidence Noun: Refers to the number of epileptic seizures within a time period or the number of seizure days per unit of time.
Regular, irregular Consistent (inconsistent) or predictable (unpredictable, chaotic) intervals between such events.
Cluster Incidence of epileptic seizures within a given period (usually one or a few days) which exceeds the average of incidence over a longer period for the patient. Cluster seizures can be defined clinically as two or more seizures within a 24-h period.
Provocative factor Noun: Transient and sporadic endogenous or exogenous element capable of augmenting seizure incidence in the patient with chronic epilepsy and evoking seizures in susceptible non-epileptic individuals.
Reactive A reactive seizure is a seizure occurring as a natural response from the normal brain to a transient disturbance in function (metabolic or toxic in nature)—which is reversible when the cause or disturbance is rectified. A provoked seizure can be considered as being synonymous with a reactive seizure.
Reflex Objectively and consistently demonstrated to be evoked by a specific afferent stimulus or by activity of the patient. Afferent stimuli can be: elementary, i.e. unstructured (light flashes, startle, a monotone sound) or elaborate i.e. structured, (a symphony). Activity may be elementary, e.g. motor (a movement).
Duration Time between the beginning of initial epileptic seizure manifestations, such as the e.g., focal epileptic seizure signs or full body convulsions to the cessation of experienced or observed epileptic seizure activity. Does not include non-specific seizure premonitions or postictal states.
Status epilepticus An epileptic seizure which shows no clinical signs of arresting after a duration encompassing the great majority of seizures of that type in most patients or recurrent epileptic seizures without resumption of baseline central nervous system function interictally. Status epilepticus can be defined clinically as (a) greater than 5 min of continuous epileptic seizures or (b) two or more discrete epileptic seizures between which there is incomplete recovery of consciousness (for generalized convulsive seizures).
Severity A multicomponent assessment of an epileptic seizure by observers and the patient.
Components primarily of observer assessment include: duration, extent of motor involvement, impairment of interaction with environment intra-ictally, maximum number of seizures per unit of time.
Prodrome A pre-ictal phenomenon. A subjective or objective clinical alteration that heralds the onset of an epileptic seizure but does not form part of it. Prodrome is a long lasting event (hours to days) and should not be confused with focal onset seizure signs which are very brief events (seconds to minutes).
Postictal phenomenon A transient clinical abnormality of central nervous system function that appears or becomes accentuated when clinical signs of the ictus have ended.
Lateralising (TODD‘S (or bravais’)) phenomenon Any unilateral postictal dysfunction relating to motor, somatosensory and/or integrative functions including visual, auditory or somatosensory.
Non-lateralising phenomenon Behavioural changes such as fear, aggression, increased appetite.
International Veterinary Epilepsy Task Force
International League Against Epilepsy
Jokinen TS, Metsähonkala L, Bergamasco L, Viitmaa R, Syrjä P, Lohi H, et al. Benign familial juvenile epilepsy in Lagotto Romagnolo dogs. J Vet Intern Med. 2007;21(3):464–71.
Seppala EH, Jokinen TS, Fukata M, Fukata Y, Webster MT, Karlsson EK, et al. LGI2 truncation causes a remitting focal epilepsy in dogs. PLoS Genet. 2011;7(7):e1002194.
Seppala EH, Koskinen LLE, Gulløv CH, Jokinen P, Karlskov-Mortensen P, Bergamasco L, et al. Identification of a novel idiopathic epilepsy locus in Belgian Shepherd dogs. PLoS One. 2012;7(3):e33549.
Stassen W, van Steenbeek F, van Rhijn N, Tenwolde R, Leegwater P. Identification of a novel epilepsy gene in Boerboel dogs. J Vet Intern Med. 2013;27:30.
Shorvon S. The concept of symptomatic epilepsy and the complexities of assigning cause in epilepsy. Epilepsy Behav. 2014;32C:1–8.
Kearsley-Fleet L, O’Neill DG, Volk HA, Church DB, Brodbelt DC. Prevalence and risk factors for canine epilepsy of unknown origin in the UK. Vet Rec. 2013;172(13):338.
Heske L, Nodtvedt A, Jaderlund KH, Berendt M, Egenvall A. A cohort study of epilepsy among 665,000 insured dogs: incidence, mortality and survival after diagnosis. Vet J. 2014;202(3):471–6.
Famula TR, Oberbauer AM, Brown KN. Heritability of epileptic seizures in the Belgian tervueren. J Small Anim Pract. 1997;38(8):349–52.
Jaggy A, Faissler D, Gaillard C, Srenk P, Graber H. Genetic aspects of idiopathic epilepsy in Labrador retrievers. J Small Anim Pract. 1998;39(6):275–80.
Kathmann I, Jaggy A, Busato A, Bartschi M, Gaillard C. Clinical and genetic investigations of idiopathic epilepsy in the Bernese mountain dog. J Small Anim Pract. 1999;40(7):319–25.
Nielen AL, Knol BW, van Hagen MA, van der Gaag I. Genetic and epidemiological investigation of a birth cohort of boxers. Tijdschr Diergeneeskd. 2003;128(19):586–90.
Berendt M, Gredal H, Pedersen LG, Alban L, Alving J. A cross-sectional study of epilepsy in Danish Labrador Retrievers: prevalence and selected risk factors. J Vet Intern Med. 2002;16(3):262–8.
Patterson EE, Mickelson JR, Da Y, Roberts MC, McVey AS, O’Brien DP, et al. Clinical characteristics and inheritance of idiopathic epilepsy in Vizslas. J Vet Intern Med. 2004;17(3):319–25.
Patterson EE, Armstrong PJ, O’Brien DP, Roberts MC, Johnson GS, Mickelson JR. Clinical description and mode of inheritance of idiopathic epilepsy in English springer spaniels. J Am Vet Med Assoc. 2005;226(1):54–8.
Casal ML, Munuve RM, Janis MA, Werner P, Henthorn PS. Epilepsy in Irish Wolfhounds. J Vet Intern Med. 2006;20(1):131–5.
Berendt M, Gulløv CH, Christensen SLK, Gudmundsdottir H, Gredal H, Fredholm M, et al. Prevalence and characteristics of epilepsy in the Belgian shepherd variants Groenendael and Tervueren born in Denmark 1995–2004. Acta Vet Scand. 2008;50:51.
Kloene J, Sewell A, Hamann H, Distl O, Tipold A. Klinische Untersuchungen zu Krampfanfällen bei Border Terriern. Kleintierpraxis. 2008;8(1):5–12.
Berendt M, Gulløv CH, Fredholm M. Focal epilepsy in the Belgian shepherd: evidence for simple Mendelian inheritance. J Small Anim Pract. 2009;50(12):655–61.
Gulløv CH, Toft N, Baadsager MMN, Berendt M. Epilepsy in the Petit Basset Griffon Vendeen: Prevalence, Semiology, and Clinical Phenotype. J Vet Intern Med. 2011;25(6):1372–8.
Oberbauer A, Grossman D, Irion D, Schaffer A, Eggleston M, Famula T. The genetics of epilepsy in the Belgian tervuren and sheepdog. J Heredity Vol. 2003;94:57–63.
Oberbauer AM, Belanger JM, Grossman DI, Regan KR, Famula TR. Genome-wide linkage scan for loci associated with epilepsy in Belgian shepherd dogs. BMC Genet. 2010;11:35.
Ekenstedt KJ, Oberbauer AM. Inherited Epilepsy in Dogs. Top Companion Anim Med. 2013;28(2):51–8.
Hülsmeyer V, Zimmermann R, Brauer C, Sauter-Louis C, Fischer A. Epilepsy in Border Collies: clinical manifestation, outcome, and mode of inheritance. J Vet Intern Med. 2010;24(1):171–8.
Weissl J, Hulsmeyer V, Brauer C, Tipold A, Koskinen LL, Kyöstilä K, Lohi H, Sauter-Louis C, Wolf M, Fischer A. Disease Progression and Treatment Response of Idiopathic Epilepsy in Australian Shepherd Dogs. J Vet Int Med 2012;26:116-125.
Licht BG, Lin S, Luo Y, Hyson LL, Licht MH, Harper KM, et al. Clinical characteristics and mode of inheritance of familial focal seizures in Standard Poodles. J Am Vet Med Assoc. 2007;231(10):1520–8.
Hülsmeyer VI, Fischer A, Mandigers P, DeRisio L, Berendt M, Rusbridge C, et al. Current evidence for idiopathic epilepsy in purebred dogs. BMC veterinary research 2015. (In press).
Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, Van Emde BW, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia. 2010;51(4):676–85.
Berg AT, Scheffer IE. New concepts in classification of the epilepsies: Entering the 21st century. Epilepsia. 2011;52(6):1058–62.
Shorvon SD. The etiologic classification of epilepsy. Epilepsia. 2011;52(6):1052–7.
Fisher RS, Van Emde BW, Blume W, Elger C, Genton P, Lee P, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46(4):470–2.
Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981. 22(4):489–501.
Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989. 30(4):389–399.
Guidelines for epidemiologic studies on epilepsy. Commission on Epidemiology and Prognosis, International League Against Epilepsy. Epilepsia 1993. 34(4):592–596.
Proposal for classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1985. 26(3):268–278.
Berendt M, Gram L. Epilepsy and seizure classification in 63 dogs: a reappraisal of veterinary epilepsy terminology. J Vet Intern Med. 1999;13(1):14–20.
Podell M: Seizures. In: BSAVA Manual of Canine and Feline Neurology. edn. Edited by Platt S, Olby N. BSAVA; 2013. 117–135.
Mariani CL. Terminology and Classification of Seizures and Epilepsy in Veterinary Patients. Top Companion Anim Med. 2013;28(2):34–41.
Licht BG, Licht MH, Harper KM, Lin S, Curtin JJ, Hyson LL, et al. Clinical presentations of naturally occurring canine seizures: similarities to human seizures. Epilepsy Behav. 2002;3(5):460–70.
Srenk P, Jaggy A. Interictal electroencephalographic findings in a family of golden retrievers with idiopathic epilepsy. J Small Anim Pract. 1996;37(7):317–21.
Podell M, Fenner WR, Powers JD. Seizure classification in dogs from a nonreferral-based population. J Am Vet Med Assoc. 1995;206(11):1721–8.
Heynold Y, Faissler D, Steffen F, Jaggy A. Clinical, epidemiological and treatment results of idiopathic epilepsy in 54 labrador retrievers: a long-term study. J Small Anim Pract. 1997;38(1):7–14.
Jaggy A, Bernardini M. Idiopathic epilepsy in 125 dogs: a long-term study. Clinical and electroencephalographic findings. J Small Anim Pract. 1998;39(1):23–9.
Morita T, Shimada A, Takeuchi T, Hikasa Y, Sawada M, Ohiwa S, et al. Cliniconeuropathologic findings of familial frontal lobe epilepsy in Shetland sheepdogs. Can J Vet Res. 2002;66(1):35–41.
Chang Y, Mellor DJ, Anderson TJ. Idiopathic epilepsy in dogs: owners’ perspectives on management with phenobarbitone and/or potassium bromide. J Small Anim Pract. 2006;47(10):574–81.
Volk HA, Matiasek LA, Luján Feliu-Pascual A, Platt SR, Chandler KE. The efficacy and tolerability of levetiracetam in pharmacoresistant epileptic dogs. Vet J. 2008;176(3):310–9.
Pákozdy A, Leschnik M, Tichy AG, Thalhammer JG. Retrospective clinical comparison of idiopathic versus symptomatic epilepsy in 240 dogs with seizures. Acta Vet Hung. 2008;56(4):471–83.
Beghi E. New classification proposals for epilepsy: a real advancement in the nosography of the disease? Epilepsia. 2011;52(6):1197–8. discussion 1205–1199.
Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE Official Report: A practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–82.
De Risio L, Bhatti S, Muñana KR, Penderis J, Stein VM, Tipold A, et al. International Veterinary Epilepsy Task Force Consensus Proposal: Diagnostic approach to epilepsy in dogs. BMC veterinary research 2015.
Lohi H, Young EJ, Fitzmaurice SN, Rusbridge C, Chan EM, Vervoort M, et al. Expanded repeat in canine epilepsy. Science. 2005;307(5706):81.
Blume WT, Lüders HO, Mizrahi E, Tassinari C, van Emde BW, Engel J. Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia. 2001;42(9):1212–8.
The authors are grateful to all owners of epileptic pets and veterinary colleagues who have inspired the group to create consensus statements. We thank all the breeders and breed clubs for their support. We would especially like to thank Professor Simon Shorvon for the critical review of the consensus statements. His great insight has been immensely helpful. The authors also would like to thank the research office for assessing the manuscript according to the Royal Veterinary College’s code of good research practice (Authorisation Number – CCS_ 01023). This study was not financially supported by any organization or grant.
Other members of the classification, definition and terminology working group (alphabetically listed).
Following reimbursements, fees and funding have been received by the authors in the last three years and have been declared in the competing interest section. CR, RGF, HAV, KM and JP have received fees for acting as a consultant for Boehringer Ingelheim (KM, MP: consultancy during development and approval of imepitoin; CR: pain consultancy; RGF, JP, HAV: consultancy pre and post launch of imepitoin). AT has been an advisor for Boehringer Ingelheim. SFMB, HAV and AT have been responsible principal investigator of several research studies concerning imepitoin financed by Boehringer Ingelheim. SFMB, HAV, JP, HP, MB, CR and AF received speaking fees from Boehringer Ingelheim. HP received consulting and speaking fees and funding for a collaborative project from Eisai Co. LTD. HAV received funding for a collaborative project from Desitin and Nestlé Purina Research. AF and LDR received reimbursements from Boehringer Ingelheim. LDR has received consulting and speaking fees from Vetoquinol. MP has received consultant fees for Aratana. The other authors declared that they have no competing interests.
MB chaired the classification, definition and terminology working group (MB, RGF, PJJM, AP) and wrote the first draft of the consensus paper with the help of RGF, PJJM, AP and HAV. HAV designed and analysed the questionnaire to facilitate the discussion about the definitions listed in the glossary. All authors read, critiqued, commented and approved the final manuscript.
Chair of IVETF: Holger A Volk, Department of Clinical Science and Services, Royal Veterinary College, Hatfield, Hertfordshire, UK; firstname.lastname@example.org.
All other co-authors are members of IVETF, are listed alphabetically and have approved the consensus statements.